Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors

Pediatric Blood and Cancer

Volumn 46, Issue 4, 2006, Pages 422-433

  Pulsipher, Michael A ^a,d   Nagler, Arnon ^b   Iannone, Robert ^c   Nelson, Robert M ^c  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Ethics of bone marrow donation; Granulocyte colony stimulation factor; Pediatric bone marrow transplantation; Pediatric donor safety

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ABSCESS; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ANAPHYLAXIS; APHERESIS; ARTICLE; BACKACHE; BACTEREMIA; BLEEDING; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CHILD; DISEASE SEVERITY; DRUG EFFECT; ETHICS; FATIGUE; FEMALE; FEVER; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS; HIGH RISK POPULATION; HUMAN; HYPOTENSION; INFECTION; LEUKAPHERESIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTHERMIA; NAUSEA; NEUROPATHY; ORGAN DONOR; PARALYSIS; PRIORITY JOURNAL; RECIPIENT; RISK BENEFIT ANALYSIS; SAFETY; SEIZURE; SIDE EFFECT; SORE THROAT; STANDARD; STROKE; SYNCOPE; URINE RETENTION; VOMITING;

BONE MARROW TRANSPLANTATION; CHILD; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKAPHERESIS; RISK ASSESSMENT; RISK FACTORS; SAFETY; TISSUE DONORS;

EID: 33644692533     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20708     Document Type: Article

References (81)

1. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001;344:175-181.
2. Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000;95:3702-3709.
3. Storek J, Gooley T, Siadak M, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997;90:4705-4709.
4. Serody JS, Sparks SD, Lin Y, et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000;6:434-440.
5. Kennedy GA, Morton J, Western R, et al. Impact of stem cell donation modality on normal donor quality of life: A prospective randomized study. Bone Marrow Transplant 2003;31:1033-1035.
6. Isola LM, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997;20:1033-1037.
7. Couban S, Messner HA, Andreou P, et al. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: A study of 29 patients. Biol Blood Marrow Transplant 2000;6:422-427.
8. Diaz MA, Vicent MG, Gonzalez ME, et al. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients. Bone Marrow Transplant 2004;34:433-438.
9. Levine JE, Wiley J, Kletzel M, et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Bone Marrow Transplant 2000;25:13-18.
10. Watanabe T, Takaue Y, Kawano Y, et al. HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents. Biol Blood Marrow Transplant 2002;8:26-31.
11. Eapen M, Horowitz MM, Klein JP, et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004;22:4872-4880.
12. Ryan R. Pediatric Blood and Marrow Transplantation Database, (personal communication).
13. Fleck LM. Children and organ donation: Some cautionary remarks. Camb Q Healthc Ethics 2004;13:161-166.
14. Jansen LA. Child organ donation, family autonomy, and intimate ' attachments. Camb Q Healthc Ethics 2004;13:133-142.
15. Sheldon M. Children as organ donors: A persistent ethical issue. Camb Q Healthc Ethics 2004;13:119-122.
16. Zinner S. Cognitive development and pediatric consent to organ donation. Camb Q Healthc Ethics 2004;13:125-132.
17. Pentz RD, Chan KW, Neumann JL, et al. Designing an ethical policy for bone marrow donation by minors and others lacking capacity. Camb Q Healthc Ethics 2004;13:149-155.
18. Buckner CD, Petersen FB, Bolonski BA. Bone Marrow Donors. In: Forman SJ, Blume KG, Thomas D, editors. Bone Marrow Transplantation. Maiden, MA: Blackwell Scientific Publications, 1994. pp 259-269.
19. Buckner CD, Clift RA, Sanders JE, et al. Marrow harvesting from normal donors. Blood 1984;64:630-634.
20. Stroncek DF, Holland PV, Bartch G, et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 1993;81:1940-1946.
21. Confer DL. Hematopoietic Cell Donors. In: Blume KG, Forman SJ, Appelbaum F, editors. Thomas' Hematopoietic Cell Transplantation. Vol. 1. Malden, Massachusetts: Blackwell Publishing, 2004. pp 538-549.
22. Confer DL. Adult allodonor stem cell collection safety issues. Safeguarding adult and pediatric stem cell donors: Basic science, clinical, and ethical issues. Arlington, VA: 2004.
23. Sanders J, Buckner CD, Bensinger WI, et al. Experience with marrow harvesting from donors less than 2 years of age. Bone Marrow Transplant 1987;2:45-50.
24. Urban C, Weber G, Slave I, et al. Anesthetic management of marrow harvesting from a 7-week-old premature baby. Bone Marrow Transplant 1990;6:443-444.
25. Chan KW, Gajewski JL, Supkis D Jr., et al. Use of minors as bone marrow donors: Current attitude and management. A survey of 56 pediatric transplantation centers. J Pediatr 1996;128:644-648.
26. de La Rubia J, Diaz MA, Verdeguer A, et al. Donor age-related differences in PBPC mobilization with rHuG-CSF. Transfusion 2001;41:201-205.
27. Kawano Y, Takaue Y, Watanabe T, et al. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors. Cancer Res 1999;59:3321-3324.
28. Pulsipher MA, Levine JE, Hayashi RJ, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant 2005;35:361-367.
29. Frangoul H, Woolfrey A, Khan S, et al. A prospective study of G-CSF primed bone marrow from pediatric donors as a stem cell source for allogeneic bone marrow transplant: a pediatric blood and marrow transplant consortium (PBMTC) study. Blood 2005;106:556a.
30. Anderlini P, Przepiorka D, Champlin R, et al. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-2825.
31. Favre G, Beksac M, Bacigalupo A, et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant 2003;32:873-880.
32. Fortanier C, Kuentz M, Sutton L, et al. Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: Results of a randomised study. Bone Marrow Transplant 2002;29:145-149.
33. Heldal D, Brinch L, Tjonnfjord G, et al. Donation of stem cells from blood or bone marrow: Results of a randomised study of safety and complaints. Bone Marrow Transplant 2002;29:479-486.
34. Bredeson C, Leger C, Couban S, et al. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biol Blood Marrow Transplant 2004;10:405-414.
35. Karlsson L, Quinlan D, Guo D, et al. Mobilized blood cells vs bone marrow harvest: Experience compared in 171 donors with particular reference to pain and fatigue. Bone Marrow Transplant 2004;33:709-713.
36. Switzer GE, Goycoolea JM, Dew MA, et al. Donating stimulated peripheral blood stem cells versus bone marrow: Do donors experience the procedures differently? Bone Marrow Transplant 2001;27:917-923.
37. Anderlini P. Special Donor Safety Seminar, EBMT. 2004.
38. Ehninger G. German Donor Registry Program. Safeguarding Adult and Pediatric Stem Cell Donors: Basic Science, Clinical, and Ethical Issues. Arlington, VA: 2004.
39. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003;72:82-93.
40. Platzbecker U, Prange-Krex G, Bornhauser M, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001;41:184-189.
41. Stroncek DF, Dittmar K, Shawker T, et al. Transient spleen enlargement in peripheral blood progenitor cell donors given G-CSF. J Transl Med 2004;2:25.
42. Stroncek D, Shawker T, Follmann D, et al. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003;43:609-613.
43. Dincer AP, Gottschall J, Margolis DA. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization. J Pediatr Hematol Oncol 2004;26:761-763.
44. Kroger N, Renges H, Sonnenberg S, et al. Stem cell mobilisation with 16 microg/kg versus 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplant 2002;29:727-730.
45. Pitini V, Ciccolo A, Arrigo C, et al. Spontaneous rupture of spleen during periferal blood stem cell mobilization in a patient with breast cancer. Haematologica 2000;85:559-560.
46. Falzetti F, Aversa F, Minelli O, et al. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999;353:555.
47. Rosenthal J, Healey T, Ellis R, et al. A 2-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. J Pediatr 1996;128:135-137.
48. Cavallaro AM, Lilleby K, Majolino I, et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000;25:85-89.
49. Anderlini P, Chan FA, Champlin RE, et al. Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: No evidence of increased risk of leukemia development. Bone Marrow Transplant 2002;30:661-663.
50. Storek J, Dawson MA, Maloney DG. et al. Cell counts in healthy donors at 1 year after blood stem cell harvesting. Blood 2000;95:2993-2994.
51. Gratwohl A. Personal Communication. 2004.
52. Amiel A, Elis A, Blumenthal D, et al. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 2001;125:156-160.
53. Amiel A, Elis A, Sherker S, et al. The influence of cytogenetic aberrations on gene replication in chronic lymphocytic leukemia patients. Cancer Genet Cytogenet 2001;125:81-86.
54. Amiel A, Litmanovitch T, Lishner M, et al. Temporal differences in replication timing of homologous loci in malignant cells derived from CML and lymphoma patients. Genes Chromosomes Cancer 1998;22:225-231.
55. Korenstein-Ilan A, Amiel A, Lalezari S, et al. Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies. Cancer Genet Cytogenet 2002;139:97-103.
56. Nagler A, Korenstein-Ilan A, Amiel A, et al. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004;32:122-130.
57. Nagler A, Toren A, Samuel S, et al. Effect of Granulocyte colony stimulating factor (G-CFS) administration for stem cell mobilization on temporal order of allelic replication. Blood 1999;94:605a.
58. Shapira MY, Kaspler P, Samuel S, et al. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors. Am J Hematol 2003;73:33-36.
59. Kaplinsky C, Trakhtenbrot L, Hardan I, et al. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplant 2003;32:31-34.
60. Cheyette C. Organ harvests from the legally incompetent: An argument against compelled altruism. Boston Coll Law Rev 2000;41:465-515.
61. Burroughs TE, Waterman AD, Hong BA. One organ donation, three perspectives: Experiences of donors, recipients, and third parties with living kidney donation. Prog Transplant 2003;13:142-150.
62. Franklin PM, Crombie AK. Live related renal transplantation: Psychological, social, and cultural issues. Transplantation 2003;76:1247-1252.
63. Fost N. Children as renal donors. N Engl J Med 1977;296:363-367.
64. Jacobs C, Johnson E, Anderson K, et al. Kidney transplants from living donors: How donation affects family dynamics. Adv Ren Replace Ther 1998;5:89-97.
65. Karrfelt HM, Berg UB, Lindblad FI, et al. To be or not to be a living donor: Questionnaire to parents of children who have undergone renal transplantation. Transplantation 1998;65:915-918.
66. MacLeod KD, Whitsett SF, Mash EJ, et al. Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HSCT): A qualitative study of their psychosocial experience. JPediatr Psychol 2003;28:223-230.
67. Packman W, Gong K, VanZutphen K, et al. Psychosocial adjustment of adolescent siblings of hematopoietic stem cell transplant patients. J Pediatr Oncol Nurs 2004;21:233-248.
68. Shama WI. The experience and preparation of pediatric sibling bone marrow donors. Soc Work Health Care 1998;27:89-99.
69. Holm S. The child as organ and tissue donor: Discussions in the Danish Council of Ethics. Camb Q Healthc Ethics 2004;13:156-160.
70. Ladd RE. The child as living donor: Parental consent and child assent. Camb Q Healthc Ethics 2004;13:143-148.
71. Glannon W, Ross LF. Do genetic relationships create moral obligations in organ transplantation? Camb Q Healthc Ethics 2002;11:153-159.
72. Food and Drug Administration. 21 CFR Parts 50 and 56: Additional safeguards for children in clinical investigations of FDA-regulated products. Federal Register 2001;66:20589-20600.
73. Department of Health and Human Services. 45 CFR Part 46: Additional protections for children involved as subjects in research. Federal Register 1983;48:9814.
74. Department of Health and Human Services. 45 CFR Part 46: Federal policy for the protection of human subjects: Additional protections for children involved as subjects in research. Technical amendment. Federal Register 1991:56:28032.
75. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Research Involving Children: Report and Recommendations. Washington, DC: U.S. Government Printing Office, 1977.
76. Field M, Behrman R, editors. Ethical Conduct of Clinical Research Involving Children. Washington, DC: The National Academies Press, 2004.
77. Nelson R. Pediatric research: The newly established process for federal review of pediatric research protocols. Med Res Law Policy 2004;3:965.
78. Shah S, Whittle A, Wilfond B, et al. How do institutional review boards apply the federal risk and benefit standards for pediatric research? Jama 2004;291:476-482.
79. Hasenclever D, Sextro M. Safety of AlloPBPCT donors: Biometrical considerations on monitoring long term risks. Bone Marrow Transplant 1996;17(Suppl 2):S28-S30.
80. Gluckman E, Socie G, Guivarch C, et al. The long time forgotten HLA identical bone marrow donor: Result of a survey on 818 patients. Blood 1996;88:612a.
81. Gunz FW, Gunz JP, Veale AM, et al. Familial leukaemia: A study of 909 families. Scand J Haematol 1975;15:117-131.